Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120.
about
The Antibody Response against HIV-1Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies.Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infectionsHuman immunodeficiency virus type-1 (HIV-1) continues to evolve in presence of broadly neutralizing antibodies more than ten years after infection.A mechanistic understanding of allosteric immune escape pathways in the HIV-1 envelope glycoprotein.epitopes immediately below the base of the V3 loop of gp120 as targets for the initial autologous neutralizing antibody response in two HIV-1 subtype B-infected individuals.Passively transmitted gp41 antibodies in babies born from HIV-1 subtype C-seropositive women: correlation between fine specificity and protection.Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7Identification of HIV-1 genitourinary tract compartmentalization by analyzing the env gene sequences in urineHeterogeneity in neutralization sensitivities of viruses comprising the simian immunodeficiency virus SIVsmE660 isolate and vaccine challenge stock.Platelet Factor 4 Inhibits and Enhances HIV-1 Infection in a Concentration-Dependent Manner by Modulating Viral AttachmentHIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity.Primary infection by a human immunodeficiency virus with atypical coreceptor tropismIdentification and characterization of an immunogenic hybrid epitope formed by both HIV gp120 and human CD4 proteins.
P2860
Q27000889-A76FC96B-F99E-42CD-81F0-780F7F3B8C21Q34016211-9C6119D4-18FD-442D-A42C-957987C9E44AQ34042642-35571347-3090-4BD8-9AA6-6250601C0693Q34407843-AB3648C8-995D-4AD1-BC2B-88502895BEE8Q34733504-8234B602-4037-4F3C-A306-8C728B59341EQ35192660-0AC6A7E3-739F-40BB-9169-21FC0901732FQ35867981-6AC55960-9B2A-41F3-8D18-515B9649EF68Q36000722-8F9562EE-1070-4F05-8826-142366632686Q36455106-95DE713F-9C91-4D16-B1D7-51C5A961097BQ36827377-6ED6BE55-D5D9-4BE3-92BD-DA808322D568Q37062259-BFD67882-7282-4094-A891-F6889158CCFBQ37360774-8EB7EF98-6E7B-4A2E-B6F6-216DA8AD3103Q38631923-57B4D4CA-26CF-4E86-8C8D-E439C7844655Q39668082-60A4802F-95EA-439C-91B3-0AC0E0E3F1B5
P2860
Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Identification of amino acid s ...... virus type-1 subtype C gp120.
@ast
Identification of amino acid s ...... virus type-1 subtype C gp120.
@en
Identification of amino acid s ...... virus type-1 subtype C gp120.
@nl
type
label
Identification of amino acid s ...... virus type-1 subtype C gp120.
@ast
Identification of amino acid s ...... virus type-1 subtype C gp120.
@en
Identification of amino acid s ...... virus type-1 subtype C gp120.
@nl
prefLabel
Identification of amino acid s ...... virus type-1 subtype C gp120.
@ast
Identification of amino acid s ...... virus type-1 subtype C gp120.
@en
Identification of amino acid s ...... virus type-1 subtype C gp120.
@nl
P2093
P2860
P50
P1433
P1476
Identification of amino acid s ...... virus type-1 subtype C gp120.
@en
P2093
Chanda Mulenga
Jennifer Hamilton
Jennifer L Kirchherr
Marcus Daniels
Rosemary M Musonda
Victor Chalwe
Webster Kasongo
Xiaozhi Lu
P2860
P304
P356
10.1016/J.VIROL.2010.09.031
P407
P577
2010-10-30T00:00:00Z